Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 124-133
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.124
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.124
Table 2 Overall incidence, number of episodes and causative bacteria of infections in patients from the polymorphism group and the wild-type group during follow-up
Polymorphism group (n = 28) | Wild-type group (n = 230) | P value | |
Total infections | |||
Patients (%) | 22 (78.6) | 171 (74.3) | 0.81 |
Number of infections | 63 | 437 | |
Number per patient | 2.25 ± 2.40 | 1.92 ± 2.19 | 0.46 |
Infections caused by gram-negative bacilli | |||
Patients (%) | 11 (39.2) | 102 (44.3) | 0.84 |
Number per patient | 0.86 ± 1.84 | 0.77 ± 1.25 | 0.75 |
Infections caused by gram-positive cocci | |||
Patients (%) | 14 (50) | 87 (37.8) | 0.22 |
Number per patient | 0.64 ± 0.73 | 0.60 ± 1.009 | 0.83 |
- Citation: Alvarado-Tapias E, Guarner-Argente C, Oblitas E, Sánchez E, Vidal S, Román E, Concepción M, Poca M, Gely C, Pavel O, Nieto JC, Juárez C, Guarner C, Soriano G. Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites. World J Hepatol 2018; 10(1): 124-133
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/124.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.124